Impact of unruptured brain aneurysms on mental health

Impact of Observation Versus Treatment on The Psychiatric and Mental Outcomes of Patients With Unruptured Intracranial Aneurysms

NA · Montefiore Medical Center · NCT06123325

This study looks at how knowing you have an untreated brain aneurysm affects anxiety and depression in patients, comparing those who get treatment with those who don’t.

Quick facts

PhaseNA
Study typeInterventional
Enrollment120 (estimated)
Ages18 Years to 75 Years
SexAll
SponsorMontefiore Medical Center (other)
Locations1 site (The Bronx, New York)
Trial IDNCT06123325 on ClinicalTrials.gov

What this trial studies

This observational study investigates how the awareness of untreated unruptured intracranial aneurysms (UIAs) affects the mental health of patients, particularly focusing on anxiety and depression. It involves a controlled, non-randomized, prospective cohort design with two arms: one receiving treatment for UIAs and the other undergoing conservative management. The study will utilize the Hospital Anxiety and Depression Scale (HADS) to assess the psychiatric outcomes of patients over a two-year period. Participants will be recruited from an outpatient clinic and will include those diagnosed with UIAs through various imaging modalities.

Who should consider this trial

Good fit: Ideal candidates are patients with unruptured intracranial aneurysms who have a modified Rankin Scale (mRS) score between 0-1.

Not a fit: Patients with a prior history of intracranial hemorrhage or severe psychiatric diseases may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could lead to improved mental health outcomes for patients diagnosed with unruptured intracranial aneurysms.

How similar studies have performed: While the specific impact of UIAs on mental health is not well-studied, similar approaches in assessing the psychological effects of chronic health conditions have shown promising results.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Unruptured intracranial aneurysms (UIA)
* mRS scores between 0-1
* Observation Group: All patients with UIAs that are eligible for conservative management

  1. Specific locations that are not good candidates for interventional treatment, such as cavernous internal carotid artery and very distally located aneurysms
  2. Aneurysm size (largest dimension) is less than 4 mm
* Treatment Group: All patients with UIAs that are decided to be treated either with endovascular or microsurgical treatments due to several reasons, such as aneurysm size above 4 mm, patient's decision

Exclusion Criteria:

* Prior history of Subarachnoid Hemorrhage (SAH)
* Prior history of intracranial aneurysm
* Severe comorbidities that impact the mental health of the patients, such severe psychiatric disease, and chronic end stage diseases
* Traumatic, mycotic, dissecting, or fusiform aneurysms
* Patients with communication barriers (does not include foreign language), developmental disability, or psychiatric illness that prevent understanding of the questions required to complete assessments
* Patients with any physical disabilities or handicaps

Where this trial is running

The Bronx, New York

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Anxiety Depression, Aneurysm Cerebral, Mental Health Wellness 1, Cerebral aneurysm, Anxiety, Depression, Endovascular, Clipping

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.